Cite

HARVARD Citation

    Wong, D. et al. (2018). HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg‐positive chronic hepatitis B patients. Alimentary pharmacology & therapeutics. 47 (1), pp. 114-122. [Online]. 
  
Back to record